A new experiment carried out by researchers has proved that Microdoses of lithium at 400 times lower than what is currently being prescribed for mood disorders are capable of slowing the signs of advanced Alzheimer’s disease in rats. Encouraged by the outcomes, researchers are keen to launch initial clinical trials of this formulation with people suffering from Alzheimer’s and Down Syndrome. They hope to find sponsors to make this happen and provide a ray of hope for an efficacious medication for those suffering from Alzheimer’s disease.